XAF1 Gene Silencing and Reactivation in Cancer Cells
Author Information
Author(s): Micali O Cristina, Cheung Herman H, Plenchette Stéphanie, Hurley Sandra L, Liston Peter, LaCasse Eric C, Korneluk Robert G
Primary Institution: Max-Planck Institute for Plant Breeding Research, Koeln, Germany
Hypothesis
The study investigates the role of XAF1 gene silencing through promoter hypermethylation and its reactivation by IFN-β in cancer cells.
Conclusion
The study provides evidence that XAF1 is a crucial mediator of IFN-induced sensitization to TRAIL in cancer cells.
Supporting Evidence
- XAF1 is a putative tumor suppressor that is silenced in various cancers due to promoter hypermethylation.
- IFN-β treatment can induce XAF1 expression even in cells with high levels of promoter methylation.
- Stable XAF1 knockdown cell lines lost sensitivity to TRAIL-induced apoptosis after IFN-β treatment.
Takeaway
The XAF1 gene helps cancer cells die when treated with a special protein called IFN-β, even if the gene is usually turned off.
Methodology
The study used bisulfite DNA modification and sequencing to assess methylation status and quantitative RT-PCR to measure gene expression.
Limitations
The analysis of methylation status was limited to 8 CpG sites within the proximal promoter region.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website